Macrophage subtypes in symptomatic carotid artery and femoral artery plaques

European Journal of Vascular and Endovascular Surgery

Volumn 44, Issue 5, 2012, Pages 491-497

  Shaikh, S ^a   Brittenden, J ^a   Lahiri, R ^b   Brown, P A J ^b   Thies, F ^a   Wilson, H M ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Atherosclerosis; M1 macrophage; M2 macrophage; Peripheral arterial disease; Plaque heterogeneity

Indexed keywords

CD3 ANTIBODY; CD68 ANTIGEN; CELL MARKER; COLLAGEN; EOSIN; HEMATOXYLIN; LIPID;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CALCIFICATION; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CELL COUNT; CELL HETEROGENEITY; CELL INFILTRATION; CONNECTIVE TISSUE; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL STUDY; FEMALE; FEMORAL ARTERY PLAQUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LIMB ISCHEMIA; MACROPHAGE; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; PHENOTYPE; PRIORITY JOURNAL; STAINING; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CONSTRICTION, PATHOLOGIC; FEMALE; FEMORAL ARTERY; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MIDDLE AGED; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; SCOTLAND; T-LYMPHOCYTES;

EID: 84867746307     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2012.08.005     Document Type: Article

References (28)

1. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
2. A.V. Finn, M. Nakano, J. Narula, F.D. Kolodgie, and R. Virmani Concept of vulnerable/unstable plaque Arterioscler Thromb Vasc Biol 30 2010 1282 1292
3. S. Jander, M. Sitzer, R. Schumann, M. Schroeter, M. Siebler, and H. Steinmetz Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization Stroke 29 1998 1625 1630
4. H.M. Wilson Macrophages heterogeneity in atherosclerosis - implications for therapy J Cell Mol Med 14 2010 2055 2065
5. O.M. Pello, C. Silvestre, M. De Pizzol, and V. Andrés A glimpse on the phenomenon of macrophage polarization during atherosclerosis Immunobiology 216 2011 1172 1176
6. A. Mantovani, C. Garlanda, and M. Locati Macrophage diversity and polarization in atherosclerosis: a question of balance Arterioscler Thromb Vasc Biol 29 2009 1419 1423
7. D.M. Mosser, and J.P. Edwards Exploring the full spectrum of macrophage activation Nat Rev Immunol 8 2008 958 969
8. A. Handberg, M. Skjelland, A.E. Michelsen, E.L. Sagen, K. Krohg-Sorensen, and D. Russell Soluble CD36 in plasma is increased in patients with symptomatic atherosclerotic carotid plaques and is related to plaque instability Stroke 39 2008 3092 3095
9. A. Kadl, A.K. Meher, P.R. Sharma, M.Y. Lee, A.C. Doran, and S.R. Johnstone Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2 Circ Res 107 2010 737 746
10. W. Zhou, H. Chai, R. Ding, and H.Y.C. Lim Distribution of inflammatory mediators in carotid and femoral plaques J Am Assoc Surgeons 211 2010 92 98
11. R.X. Du, L. Fan, X.Y. Li, and L.X. Wei The pathology investigation of femoral artery atherosclerosis in the elder patients Zhonghua Bing Li Xue Za Zhi 34 2005 154 158
12. F. Herisson, M.F. Heymann, M. Chétiveaux, C. Charrier, S. Battaglia, and P. Pilet Carotid and femoral atherosclerotic plaques show different morphology Atherosclerosis 216 2011 348 354
13. North American Symptomatic Carotid Endarterectomy Trial Collaborators Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis N Engl J Med 325 1991 445 453
14. Scottish Intercollegiate Guidelines Network (SIGN) Diagnosis and management of peripheral arterial disease. A national clinical guideline. (SIGN guideline 89) October 2006
15. Scottish Intercollegiate Guidelines Network (SIGN) Management of patients with stroke or TIA: assessment, investigation, immediate management and secondary prevention. A national clinical guideline, (SIGN guideline 108) December 2008
16. J.M. Cai, T.S. Hatsukami, M.S. Ferguson, R. Small, N.L. Polissar, and C. Yuan Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging Circulation 106 2002 1368 1373
17. W.E. Hellings, G. Pasterkamp, B.A. Verhoeven, D.P. De Kleijn, J.P. De Vries, and K.A. Seldenrijk Gender-associated differences in plaque phenotype of patients undergoing carotid endarterectomy J Vasc Surg 45 2007 289 296
18. Y. Liu, K.N. Stewart, E. Bishop, C.J. Marek, D.C. Kluth, and A.J. Rees Unique expression of suppressor of cytokine signalling 3 is essential for classical macrophage activation in rodents in vitro and in vivo J Immunol 180 2008 6270 6278
19. J.A. Willment, H.H. Lin, D.M. Reid, P.R. Taylor, D.L. Williams, and S.Y. Wong Dectin-1 expression and function are enhanced on alternatively and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide J Immunol 171 2003 4569 4573
20. C.S. Whyte, E.T. Bishop, D. Rückerl, S. Gaspar-Pereira, R.N. Barker, and J.E. Allen Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function J Leukoc Biol 90 2011 845 854
21. M.A. Bouhlel, B. Derudas, E. Rigamonti, R. Dièvart, J. Brozek, and S. Haulon PPAR gamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties Cell Metab 6 2007 137 143
22. S.W. Waldo, Y. Li, C. Buono, B. Zhao, E.M. Billings, and J. Chang Heterogeneity of human macrophages in culture and in atherosclerotic plaques Am J Pathol 172 2008 1112 1126
23. J. Khallou-Laschet, A. Varthaman, G. Fornasa, C. Compain, A.T. Gaston, and M. Clement Macrophage plasticity in experimental atherosclerosis PLoS One 5 2010 e8852
24. W.J. Derksen, J.P. de Vries, A. Vink, E. Velema, J.A. Vos, and D. de Kleijn Histologic atherosclerotic plaque characteristics are associated with restenosis rates after endarterectomy of the common and superficial femoral arteries J Vasc Surg 52 2010 592 599
25. R.M. Kwee Systematic review on the association between calcification in carotid plaques and clinical symptoms J Vasc Surg 51 2010 1015 1025
26. A. Farb, A.P. Burke, A.L. Tang, T.Y. Liang, P. Mannan, and J. Smialek Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death Circulation 93 1996 1354 1363
27. E. Fujita, A. Shimizu, Y. Masuda, N. Kuwahara, T. Arai, and S. Nagasaka Statin attenuates experimental anti-glomerular basement membrane glomerulonephritis together with the augmentation of alternatively activated macrophages Am J Pathol 177 2010 1143 1154
28. P. Quist-Paulsen Statins and inflammation: an update Curr Opin Cardiol 25 2010 399 405